| 情報源 ＞ 更に詳しい情報 ＞［005］＞ |
|
| (1) | Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: theWhickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93. |
| (2) | Vander JB, Gaston EA, Dawber TR. Signifいcance of solitary nontoxic thyroid nodules: preliminary report. N Engl J Med 1954; 251: 970-3. |
| (3) | Idem. The significance ofnontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968; 69: 537-40. |
| (4) | Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology 1991; 181: 683-7. |
| (5) | Sheppard MC, Franklyn JA. Management ofthe single thyroid nodule. Clin Endocrinol(Oxf) 1992; 37: 398-401. |
| (6) | Ridgway EC. Clinician's evaluation of a solitary thyroid nodulc. J Clin Endocrinol Metab 1992; 74: 231-5. |
| (7) | Mazzaferri EL. Management ofa solitary thyroid nodule. N Engl J Med 1993; 328: 553-9. |
| (8) | Gharib H, Goellner JR. Fine-needle aspiration biopsy ofthe thyroid: anappraisal, Ann Intcrn Med 1993; 118: 282-9. |
| (9) | Singer PA. Evaluation and management of the solitary thyroid nodule. Otolaryngol Clin North Am 1996; 29: 577-91. |
| (10) | Ain KB. Papillary thyroid carcinoma: etiology, assessment, and therapy. Endocrinol Metab Clin North Am 1995; 24: 711-60. |
| (11) | Grebe SKG, Hay ID. Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995; 24: 761-801. |
| (12) | Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998; 338: 297-306. |
| (13) | Cheung PSY, Lee JMH, Boey JH. Thyroxinc suppressive therapy of benign solitary thyroid nodules: a prospective randomized study. World J Surg 1989; 13: 818-21. |
| (14) | Kuma K, Matsuzuka F, Kobayashi A, et al. Outcome of long standing solitary thyroid nodules. World J Surg 1992; 16: 583-7. |
| (15) | Tan GH, Gharib H, Reading CC. Solitary thyroid nodule: comparison between palpation and ultrasonography. Arch Intern Med 1995; 155: 2418-23. |
| (16) | Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid: a 12-year experience with I 1,000 biopsies. Clin Lab Med 1993; 13: 699-709. |
| (17) | de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, Mazzaferri EL. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med 1990; 150: 1422-7. |
| (18) | Wiener JD. Long-term follow-up in untreated Plummer's disease (autonomous goiter). Clin Nucl Med 1987; 12: 198-203. |
| (19) | Berghout A, Wiersinga WM, Smits NI, Touber JL. Interrelationships betwcen age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 1990; 89: 602-8. |
| (20) | Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch Intern Med 1996; 156: 2165-72. |
| (21) | Rojeski MT, Gharib H. Nodular thyroid disease: evaluation and management. N Engl J Med 1985; 313: 428-36. |
| (22) | Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992; 93: 363-9. |
| (23) | Franklyn JA, Daykin J, Young J, Oates GD, Sheppard MC. Finc needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. BMJ 1993; 307: 240. |
| (24) | Edmonds CJ, Tellez M. Treatnlent of thyroid cysts by aspiration and injection of sclcrosant. BMJ 1987; 295: 529. |
| (25) | Monzani F, Lipp} F, Goletti O, et al. Percutaneous aspiration and ethanol sclerotherapy for thyroid cysts. J Clin Endocrinol Metab 1994; 78: 800-2. |
| (26) | Zingrillo M, Torlontano M, Ghiggi MR, et al. Percutaneous ethanol injection of large thyroid cystic nodules. Thyroid 1996; 6: 403-8. |
| (27) | Molitch ME, Beck JR, Dreisman M, Gottlieb JE, Pauker SG. The cold thyroid nodule: an analysis of diagnostic and therapeutic options. Endocr Rev 1984; 5: 185-99. |
| (28) | Gharib H, James EM, CharbQneau JW, Naessens JM, Offord KP, Gorman CA. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controllcd clinical study. N Engl J Med 1987; 317: 705. |
| (29) | Reverter JL, Lucas A, Salinas I, Audi L, Foz M, Sanmarti A. Suppressive therapy with levothyroxine for solitary thyroid nodules, Clin Endocrinol (Oxf) 1992; 36: 25-8. |
| (30) | Papini E, Bacci V, Panunzi C, et al. A prospective randomized trial of levothyroxine suppressive therapy for solitary thyroid nodules. Clin Endocrinol (Oxf)1993; 38: 507-13. |
| (31) | La Rosa GL, Lupo L, Giuffrida D, Gullo D, Vigneri R, Belfiore A. Levothyroxine and potassium iodide are both effective in treating benign solitary solid cold nodules of the thyroid. Ann Intern Med 1995; 122: 1-8. |
| (32) | La Rosa GL, Ippolito AM, Lupo L, et al. Cold thyroid nodule reduction with L-thyroxine can be predicted by initial nodule volume and cytological characteristics. J Clin Eridocrinol Metab 1996; 81: 4385-7. |
| (33) | Cooper DS. Thyroxine suppression therapy for benign nodular disease. J Clin Endocrinol Metab 1995; 80: 331-4. |
| (34) | Hamburger JI. Evolution of toxicity in solitary nontoxic autonomously functioning thyroid nodules. J Clin Endocrinol Metab 1980; 50: 1089-93. |
| (35) | L Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D. Longtcrm follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Copenh) 1993; 128: 51-5. |
| (36) | Studley J, Lynn J. Surgical anatomy of the thyroid gland and the technique ofthyroidectomy. In: Lynn J, Bldom SR, eds. Surgical endocrinolo-gy. Oxford, England: Butterworth-Heinemann, 1993: 231-9. |
| (37) | Kaplan EL, Shukla M, Hara H, Ito K. Surgcry of the thyroid, In: DeGroot LJ, Besser M, Burger HG, et al., eds. Endocrinology. 3rd ed. Vol. l. Philadelphia: W.B. Saunders, 1995; 900-14. |
| (38) | Beahrs OH, Vandertoli DJ. Complications of secondary thyroidectomy. Surg Gynecol Obstct 1963; 117: 535-9. |
| (39) | Rojdmark I, Jarhult J. High long term recurrence rate after subtotal thyroidectomy for nodular goitre. Eur J Sufg 1995; 161: 725-7. |
| (40) | Ross DS. Thyroid hormone suppressive therapy of sporadic nontoxic goiter. Thyroid 1992; 2: 263-9. |
| (41) | Hansen JM, Kampmann J, Madsen SN, et al. L-thyroxihe treattnent of diffuse non-toxic goitre evaluated by ultrasonic determination of thyroid volume. Clin Endocrinol (Oxf) 1979; 10: 1-6. |
| (42) | Perrild H, Hansen JM, Hegedus L, et al. Triiodothyronine and thyroxine treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinol (Copenh) 1982; 100: 382-7. |
| (43) | Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber IL. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 1990; 336: 193-7. |
| (44) | Toft AD. Thyroxine therapy. N Engl J Med 1994; 331: 174-80. [Erratum, N Engl J Med 1994; 331: 1035.] |
| (45) | Hegedus L, Hansen BM, Knudsen N, Hansen JM. Reduction ofsize of thyroid with radioactive iodine in multinodular non-toxic goitre. BMJ 1988; 297: 661-2. |
| (46) | Nygaard B, Hegedus L, Gervil M, Hjalgrim H, Soc-Jensen P, Hansen JM. Radioiodine treatment of multinodular non-toxic goitre. BMJ 1993; 307: 828-32. |
| (47) | Huysmans DAKC, Hermus ARMM, Corstens FHM, Barentsz JO, Kloppenborg
PWC. Large, compressive goiters treated with radioiodine. Ann Intern Med 1994; 121: 757-62. |
| (48) | Wesche MF, Tiel-v-Buul MM. Smits NJ, Wiersinga WM. Reduction in goiter size by 131-I therapy in patients with non-toxic multinodular goiter. Eur J Endocrinol 1995; 132: 86-7. |
| (49) | de Klerk JMH, van Isselt JW, van Dijk A, et al. Iodine-131 therapy in sporadic nontoxic goiter. J Nucl Med 199?; 38: 372-6. |
| (50) | Huysmans D, Hermus A, Edelbroek M, Barentsz J, Corstens F, Kloppenborg
P. Radioiodine for nontoxic multinodular goiter. Thyroid 1997; 235-9. |
| (51) | Nygaard B, Soes-Petersen U, Hoilund-Carlsen PF, et al. Improvement of upper airway obstruction after 131-I treatment of multinodular nontoxic goiter evaluated by flow volume loop curves. J Endocrinol Invest 1996; 19: 71-5. |
| (52) | Nygaard B, Faber J, Hegedtis L. Acute changes in thyroid volume and function fbllowing 131-I therapy of multinodular goitre. Clin Endocrinol (Oxb 1994; 41: 715-8. |
| (53) | Nygaard B, Knudsen JH, He'gediis L, Scient AV, Hansen J, EM. Thyrotropin receptor antibodies and Giraves' disease, a side-effect of 131-I treatment in patients with nontoxic goiter, J Clin Endocrinol Metab 199?; 82: 2926-30. |
| (54) | Huysmans DAKC, Hermus ARMM, Edelbroek MAL, et al. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters. Thyroid 1997; 535-9. |
| (55) | Huysmans DAKC, Buijs WCAMi van de Ven MT, et al. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters. J Nucl Med 1996; 37: 2072-9. |
| (56) | Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret GY. Effect on bone mass of long term treatment with thyroid hormones: a metaanalysis. J Clin Endocrinol Metalp 1996; 81: 4278-89. |
| (57) | Schneider DL, Barrett-Cohnor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women: effects of estrogen. JAMA 1994; 271: 1245-9. |
| (58) | Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibriilation in older persons. N Engl J Med 1994; 331: 1249-52. |
| (59) | Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1993; 77: 334-8. |
| (60) | Ching GW, Franklyn JA, Stallard TJ, Daykih, J, Sheppard MC, Gammage
MD. Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart 1996; 75: 363-8. |
| (61) | Shapiro LE, Sievert I, Ong L, et al. Minimal cardiac effects in asymptomatic athyreotic paticnts chronically treated with thyrotropin-suppressive doses of L-thyroxine. J Clin Endocrinol Metab 1997; 82: 2592-5. |
| (62) | Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994; 330: 1731-8. [Erratum, N Engl J Mcd 1994; 331: 559-1. |
| (63) | Ferrari C, Reschini E, Paratchi, A. Treatment of, the. autonomous thyroid nodule: a review. Eur J Endocrinol 1996; 135: 383-90. |
| (64) | Hay ID, Morris JC. Toxic adenoma and toxic multinodular goiter. In: Braverinan LE, 'Utiger PJ), eds. Werndr and Ingbair's the thyroid: a fundameutal and clinical text. 7th ed. Philadelphia: Lippincott.Raven. 1996; 566-72. |
| (65) | Giuffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 1995; 99: 642-50. |
| (66) | Jensen MD, Gharib H, Naessens JM van Heerden JA, Mayberry WE. Treatment of toxic multinodular goiter (Plummer's disease): surgery or radioiodine? World J Surg 1986; 10: 673-80. |
| (67) | Kinscr JA, Roesler H, Furrer T, Grtitter D, Zimmcrmann H. Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment. J Nucl Med 1989; 30: 1960-5. |
| (68) | Burch HB, Wartofsky L. Hyperthyroidism. Curr Ther Endocrinol Metab 1994; 5: 64-70. |
| (69) | Huysmans DAKC, Hermus ARMM, Corstens FHM, Kloppenborg PWC. Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre. Eur J Nucl Med 1993; 20: 1056-62. |
| (70) | Franklyn JA, Daykin J, Holder R, Sheppard MC. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. QJM-1995; 88: 175-80. |
| (71) | Hegedus L, Veiergang D, Karstrup S, Hansen JM. Compensated 131-I-therapy of solitary autonomous thyroid nodules: effect on thyroid size-and early hypothyroidism. Acta Endocrinol (Copenh) 1986; 113: 226-32. |
| (72) | Mariotti S, Martino E, Francesconi M, et al. Serum thyroid autoantibodies as a risk factor fbr development of hypothyroidism after radioactive iodine therapy for single thyroid 'hot' nodule. Acta Endocrinol (Copenh) 1986; 113: 500-7. |
| (73) | Gorman CA, Robertson JS. Radiation dose in the selection of 131-I or surgical treatment f'or toxic thyroid adenoma. Ann Intern Med 1978; 89: 85-90. |
| (74) | Holm LE, Hall P, Wiklund K, et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991; 83: 1072-7. |
| (75) | Lippi F, Ferrari C, Manetti L, et al. Treatmcnt of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study. J Clin Endocrinol Metab 1996; 81: 3261-4. |
| (76) | Monzani F, Caraccio N, loletti O, et al. Five-year follow-up of percutaneous ethanol injection for the treatinent of hyperfunctioning thyroid nodules: a study of 117 patients. Clin Endocrinol (Oxf) 1997; 46: 9-15. |
| (77) | Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995; 273: 808-12. |
| ［もどる］ |